1. Home
  2. ALKS vs SON Comparison

ALKS vs SON Comparison

Compare ALKS & SON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • SON
  • Stock Information
  • Founded
  • ALKS 1987
  • SON 1899
  • Country
  • ALKS Ireland
  • SON United States
  • Employees
  • ALKS N/A
  • SON N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • SON Containers/Packaging
  • Sector
  • ALKS Health Care
  • SON Consumer Discretionary
  • Exchange
  • ALKS Nasdaq
  • SON Nasdaq
  • Market Cap
  • ALKS 5.1B
  • SON 4.6B
  • IPO Year
  • ALKS 1991
  • SON N/A
  • Fundamental
  • Price
  • ALKS $29.05
  • SON $46.25
  • Analyst Decision
  • ALKS Strong Buy
  • SON Strong Buy
  • Analyst Count
  • ALKS 13
  • SON 8
  • Target Price
  • ALKS $40.38
  • SON $57.63
  • AVG Volume (30 Days)
  • ALKS 2.0M
  • SON 1.1M
  • Earning Date
  • ALKS 07-29-2025
  • SON 07-23-2025
  • Dividend Yield
  • ALKS N/A
  • SON 4.58%
  • EPS Growth
  • ALKS 21.99
  • SON 50.18
  • EPS
  • ALKS 2.08
  • SON 5.59
  • Revenue
  • ALKS $1,505,296,000.00
  • SON $6,337,597,000.00
  • Revenue This Year
  • ALKS N/A
  • SON $46.12
  • Revenue Next Year
  • ALKS $3.33
  • SON $0.72
  • P/E Ratio
  • ALKS $13.99
  • SON $8.28
  • Revenue Growth
  • ALKS N/A
  • SON 37.96
  • 52 Week Low
  • ALKS $25.56
  • SON $39.46
  • 52 Week High
  • ALKS $36.45
  • SON $56.77
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 60.08
  • SON 52.38
  • Support Level
  • ALKS $26.07
  • SON $44.62
  • Resistance Level
  • ALKS $28.73
  • SON $46.63
  • Average True Range (ATR)
  • ALKS 0.87
  • SON 0.93
  • MACD
  • ALKS 0.35
  • SON 0.01
  • Stochastic Oscillator
  • ALKS 97.94
  • SON 56.53

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About SON Sonoco Products Company

Over its 100-year-plus history, Sonoco Products has steadily assembled a diverse portfolio of industrial and consumer packaging product offerings such as flexible and rigid plastics, reels and spools, pallets, and composite cans. The company serves a variety of consumer and industrial end markets throughout North America. Sonoco has raised its dividend each year for more than 40 years.

Share on Social Networks: